Utilidad de las escalas de evaluación del riesgo de fractura en el paciente con diabetes tipo 2

Janghorbani, 2007, Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture, Am J Epidemiol., 166, 495, 10.1093/aje/kwm106 Schwartz, 2001, Older women with diabetes have an increased risk of fracture: a prospective study, J Clin Endocrinol Metab., 86, 32, 10.1210/jcem.86.1.7139 Vestegaard, 2005, Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk, Diabetolologia., 48, 1292, 10.1007/s00125-005-1786-3 Yamamoto, 2009, Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications, J Bone Miner Res., 24, 702, 10.1359/jbmr.081207 Hernandez, 2005, Trabecular microfracture and the influence of piridinum and non-enzymatic glycationmediated collagen crosslinks, Bone., 37, 825, 10.1016/j.bone.2005.07.019 De Liefde, 2005, Bone mineral density and fracture risk in type-2 diabetes mellitus: The Rotterdam Study, Osteoporos Int., 16, 1713, 10.1007/s00198-005-1909-1 Okazaki, 1997, Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover, J Clin Endocrinol Metab., 82, 2915 Van Geel, 2010, Individualizing fracture risk prediction, Maturitas., 65, 143, 10.1016/j.maturitas.2009.12.007 Roig Vilaseca, 2010, Riesgo de fractura de fémur: Comparación de dos modelos de cálculo, Reumatol Clin., 6, 39 Kanis, 2008, Case finding for the management of osteoporosis with FRAX –assessment and intervention thresholds for the UK, Osteoporos Int., 19, 1395, 10.1007/s00198-008-0712-1 Ismail, 2002, Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS), Osteoporos Int., 13, 565, 10.1007/s001980200074 Tosteson, 2008, Cost-effective osteoporosis treatment thresholds: the United States perspective, Osteoporos Int., 19, 437, 10.1007/s00198-007-0550-6 Comité Expertos SEIOMM, 2009, Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón, Rev Osteoporos Metab Miner., 1, 53 Disponible en: http://www.nof.org/professionals/clinical-guidelines Disponible en: http://www.shef.ac.uk/NOGG/NOGG_Pocket_Guide_for_Healthcare_Professionals.pdf Kanis, 2010, Development and use of FRAX in osteoporosis, Osteoporos Int., 21, S407, 10.1007/s00198-010-1253-y Leslie, 2011, High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice, Osteoporos Int Trémollieres, 2010, Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool, J Bone Miner Res., 25, 1002, 10.1002/jbmr.12 Naranjo, 2011, Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture, Med Clin (Barc)., 136, 290, 10.1016/j.medcli.2010.06.028 Azagra Ledesma, 2011, Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population, Med Clin (Barc)., 136, 613, 10.1016/j.medcli.2010.09.043 Azagra, 2011, Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain, BMC Musculoskelet Disord., 12, 30, 10.1186/1471-2474-12-30 Hippisley-Cox, 2009, Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores, BMJ, 339, b4229, 10.1136/bmj.b4229